Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals

touchEXPERT OPINIONS for touchENDOCRINOLOGY In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology. The experts: Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME. For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/